ACC.26 advanced registration ends Feb. 12 – register now!

Stephen L. Kopecky, MD

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Prime Therapeutics(MODEST), Amgen Inc.(MODEST) RESEARCH/RESEARCH GRANTS: True Health(SIGNIFICANT)

View Full Disclosure